Primary |
Hypertension |
50.0% |
Cardiac Failure |
12.5% |
Hypothyroidism |
12.5% |
Ischaemic Heart Disease Prophylaxis |
12.5% |
Type 2 Diabetes Mellitus |
12.5% |
|
Renal Failure Acute |
100.0% |
|
Secondary |
Product Used For Unknown Indication |
18.7% |
Hypertension |
13.2% |
Essential Hypertension |
6.6% |
Sleep Disorder |
6.6% |
Cardiac Failure |
5.5% |
Diabetes Mellitus |
4.4% |
Fluid Replacement |
4.4% |
Hyperthyroidism |
4.4% |
Hypokalaemia |
4.4% |
Polyuria |
4.4% |
Thrombosis Prophylaxis |
4.4% |
Hypothyroidism |
3.3% |
Ischaemic Heart Disease Prophylaxis |
3.3% |
Type 2 Diabetes Mellitus |
3.3% |
Acute Myocardial Infarction |
2.2% |
Agitation |
2.2% |
Diarrhoea |
2.2% |
Disorientation |
2.2% |
Gastrointestinal Ulcer |
2.2% |
Hypercholesterolaemia |
2.2% |
|
Sepsis |
28.6% |
Urinary Tract Infection |
28.6% |
Renal Failure Acute |
9.5% |
Swollen Tongue |
9.5% |
Bone Marrow Failure |
4.8% |
Drug Interaction |
4.8% |
Neutropenic Infection |
4.8% |
Tongue Haemorrhage |
4.8% |
White Blood Cell Count Decreased |
4.8% |
|
Concomitant |
Drug Use For Unknown Indication |
36.4% |
Product Used For Unknown Indication |
9.1% |
Hypertension |
8.2% |
Pain |
5.9% |
Rheumatoid Arthritis |
3.6% |
Diabetes Mellitus |
3.4% |
Pneumonia |
3.0% |
Prostate Cancer |
2.9% |
Cardiac Failure |
2.8% |
Thrombosis Prophylaxis |
2.8% |
Atrial Fibrillation |
2.5% |
Diuretic Therapy |
2.5% |
Osteoporosis |
2.5% |
Parkinson's Disease |
2.3% |
Gastroenteritis |
2.2% |
Hypokalaemia |
2.1% |
Agitation |
1.9% |
Breast Cancer Metastatic |
1.9% |
Hypercholesterolaemia |
1.9% |
Renal Failure |
1.8% |
|
Vomiting |
10.2% |
Weight Decreased |
10.2% |
Pneumonia |
8.0% |
Pyrexia |
6.8% |
Pancytopenia |
5.7% |
Rhabdomyolysis |
5.7% |
Melaena |
4.5% |
Pulmonary Embolism |
4.5% |
Sudden Death |
4.5% |
White Blood Cell Count Increased |
4.5% |
Wrong Drug Administered |
4.5% |
Arrhythmia |
3.4% |
Ascites |
3.4% |
Hemiparesis |
3.4% |
Hyponatraemia |
3.4% |
Myocardial Infarction |
3.4% |
Organising Pneumonia |
3.4% |
Pancreatitis |
3.4% |
Stevens-johnson Syndrome |
3.4% |
Tachycardia |
3.4% |
|
Interacting |
Hypertension |
50.0% |
Cardiac Failure |
12.5% |
Diabetes Mellitus |
12.5% |
Hypothyroidism |
12.5% |
Ischaemic Heart Disease Prophylaxis |
12.5% |
|
Renal Failure Acute |
100.0% |
|